Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2023-06-02

Clinical Trial Update: Geniculate Nerve Ablation vs Geniculate Artery Embolization vs Sham for Knee Osteoarthritic Pain [Phase 4]

View source ↗

Summary

Phase 4 trial comparing geniculate nerve ablation, geniculate artery embolization, and sham for knee osteoarthritis pain was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Osteoarthritis, Knee | Phase 4 | Status: WITHDRAWN